The purpose of using Positive Quality Interventions (PQIs) is to create a more positive patient experience and better outcomes, explained Neal Dave, PharmD, pharmacy manager for Texas Oncology and chair of the PQI initiative for National Community Oncology Dispensing Association (NCODA).
The purpose of using Positive Quality Interventions (PQIs) is to create a more positive patient experience and better outcomes, explained Neal Dave, PharmD, pharmacy manager for Texas Oncology and chair of the PQI initiative for National Community Oncology Dispensing Association (NCODA).
Transcript
What are Positive Quality Interventions (PQI) and the purpose of NCODA's PQI initiative?
PQI stands for Positive Quality Interventions, and, basically, we try to create documents or create an intervention that pharmacy, nursing, pharmacy technicians can make that would create a positive impact for a patient.
For instance, the first PQI that we had at NCODA was based on, you get a prescription for aromatase inhibitor—this is a few years ago, and at that time a new drug had just come out that you could add on to the aromatase inhibitor—and, so, the advantage of NCODA pharmacists and nurses is we have access to the electronic medical record, we can look at the patient, we can look at the profile, we can say, “Hey, this person, we’re getting a prescription for an aromatase inhibitor, they’re probably a candidate for this other drug.” And the process is written down and there is backing for the pharmacist, so they don’t have to go look around for the data; they can take that 1 sheet, go to the physician and say, “Hey, should we get this other prescription sent to us?”
And that, ultimately, leads to a positive patient interaction and better patient outcomes. That’s an example of a PQI. Not all of them are exactly like that, but all of them are patient focused Our end goal is to take care of patients better and share information. That’s the main goals for the Positive Quality Interventions.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More